McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in an October 16, 2013 World Trade Online article entitled, “Official Signals EU Opposed To Harmonizing Certain Drug Rules In TTIP Talks.” A European Union official close to the U.S.-EU free trade talks last week gave a clear signal that the EU will seek to avoid negotiating on the controversial issue of pharmaceutical intellectual property rights (IPR) protection as part of the initiative, and said that a final deal will address only a select number of IPR issues overall. View the article (subscription required)